Dong Chen

Dr. Dong Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCChenzhi Cui
Chenzhi Cui
TYTianke Yang
Tianke Yang
SWShengYu Wang
ShengYu Wang
ZJZhuqiang Jia
Zhuqiang Jia
LZLin Zhao
Lin Zhao
DCDong Chen
Dong Chen
Background: In the realm of Gut-Brain axis research, existing evidence points to a complex bidirectional regulatory mechanism between gut microbiota and the brain. However, the question of whether a causal relationship exists between gut microbiota and specific types of brain tumors, such as gliomas, remains unresolved. To address this gap, we employed publicly available Genome-Wide Association Study (GWAS) and MIOBEN databases, conducting an in-depth analysis using Two-Sample Mendelian Randomization (MR). Method: We carried out two sets of MR analyses. The preliminary analysis included fewer instrumental variables due to a high genome-wide statistical significance threshold (5×10−8). To enable a more comprehensive and detailed analysis, we adjusted the significance threshold to 1×10−5. We performed linkage disequilibrium analysis (R2 <0.001, clumping distance = 10,000kb) and detailed screening of palindromic SNPs, followed by MR analysis and validation through sensitivity analysis. Results: Our findings reveal a causal relationship between gut microbiota and gliomas. Further confirmation via Inverse Variance Weighting (IVW) identified eight specific microbial communities related to gliomas. Notably, the Peptostreptococcaceae and Olsenella communities appear to have a protective effect, reducing glioma risk. Conclusion: This study not only confirms the causal link between gut microbiota and gliomas but also suggests a new avenue for future glioma treatment.

30 September 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
YLYong-Jiang LI
Yong-Jiang LI
HHHui-Min Hou
Hui-Min Hou
QHQi-Fei Hu
Qi-Fei Hu
YJYuan Li Jin
Yuan Li Jin
CXChundong Xue
Chundong Xue
Kai-Rong QinKai-Rong Qin
Kai-Rong Qin
Pulsatile blood flow generates complex wall shear stress (WSS) patterns at the carotid bifurcation, which critically regulate endothelial function and structure. While physiological pulsatile WSS (PWSS) is essential for maintaining vascular health, low oscillatory WSS (OWSS) near the carotid sinus is closely associated with endothelial dysfunction, atherosclerotic plaque formation, and stenosis. Reproducing these hemodynamic conditions in vitro is therefore crucial for investigating endothelial mechanobiology and elucidating the pathogenesis of atherosclerosis. Although microfluidic technologies have emerged as promising platforms for simulating either pulsatile or oscillatory WSS, a system capable of simultaneously replicating both characteristic waveforms—as found in vivo at the carotid bifurcation—remains undeveloped. In this study, we designed a variable cross-section microfluidic channel using Computational Fluid Dynamics (CFD) simulations. Numerical results demonstrate that the optimized channel accurately reproduces low OWSS at a stepped section emulating the carotid sinus, alongside high PWSS in a downstream uniform section. Vortex formation induced by the step structure is identified as key to generating low OWSS, influenced by step height, channel width ratio, and input flow rate. This work provides a novel and robust methodology for designing microfluidic systems that mimic complex hemodynamic microenvironments, facilitating future studies on the interplay between distinct WSS patterns and endothelial dysfunction.

1 January 2025 in IET Systems Biology
Verified
Journal Article
Open access
ZXZijun Xu
Zijun Xu
BXBohan Xi
Bohan Xi
JHJiaming Huang
Jiaming Huang
LZLiqiang Zhang
Liqiang Zhang
SCSifu Cui
Sifu Cui
SLShupeng Li
Shupeng Li
Glioblastoma is a highly aggressive and devastating brain malignancy with dismal prognosis and extremely limited therapeutic options. Identification of prognostic biomarkers and therapeutic targets from multi‐omics data is critical for improving patient outcomes. In this study, we investigated the clinical significance of cellular heterogeneity and super‐enhancer‐driven regulatory networks, which are critically implicated in glioblastoma progression and treatment resistance. We first performed scRNA‐seq to dissect tumour microenvironment heterogeneity, identifying 16 distinct cell clusters, including astrocytes, macrophages, and CD8+ T cells. CellChat analysis revealed key intercellular signalling pathways, with astrocytes and macrophages acting as central communication hubs. To integrate bulk RNA sequencing data, we applied the Scissor algorithm to identify survival‐associated cell states. By combining single‐cell and bulk transcriptomic data, we uncovered 642 survival‐related genes, including QKI and RBM47, which robustly predicted patient survival and immunotherapy response. Furthermore, WGCNA analysis identified seven co‐expression modules and super enhancer‐regulated networks orchestrated by transcription factors (RFX2, RFX4) and hub genes (NEAT1, CFLAR). These networks stratified patients into high‐ and low‐risk groups with significant survival differences. Collectively, our findings elucidate the intricate interplay between cellular heterogeneity and super enhancer‐driven gene regulation in glioblastoma, providing a translational framework for targeting oncogenic hubs and modulating microenvironment interactions.

1 September 2023 in Gene
Verified
Journal Article
Closed access
TJTao Jiang
Tao Jiang
JHJiaming Huang
Jiaming Huang
SLShupeng Li
Shupeng Li
QXQiushi Xu
Qiushi Xu
TZTianding Zhang
Tianding Zhang
DCDong Chen
Dong Chen

21 January 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
WZWen Zhao
Wen Zhao
XYXuanyue Yu
Xuanyue Yu
YZYuhua Zhang
Yuhua Zhang
SCShuya Cai
Shuya Cai
JLJianwen Lin
Jianwen Lin
YLYi Liu
Yi Liu
Stroke-associated infection (SAI) is a significant complication of stroke, with approximately 30% of stroke patients developing infections, primarily respiratory and urinary tract infections. These infections can severely impact prognosis and increase the economic burden. While dysphagia is a known independent risk factor for stroke-associated pneumonia, research shows that stroke patients without aspiration or related risk factors, such as dysphagia and impaired consciousness, also exhibit a high incidence of non-aspiration stroke-associated infections (NA-SAI). This comprehensive article meticulously examines and reviews the risk factors, pathophysiological underpinnings, and therapeutic strategies for NA-SAI, with the aim of enhancing clinicians' comprehension and management of this condition.

27 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
EBEhab Balawi
Ehab Balawi
ZJZhicheng Jiang
Zhicheng Jiang
XWXianwei Wang
Xianwei Wang
DCDong Chen
Dong Chen
Background/Objectives: TGFB2 is the dominant TGF-β isoform in glioma, and isolated experimental studies have implicated it in immunosuppressive signaling; however, its prognostic value and systematic association with the tumor immune microenvironment across the diffuse glioma spectrum have not been comprehensively characterized in large clinical cohorts. Methods: A multi-cohort transcriptomic study was conducted using TCGA (n = 667) as discovery and CGGA (n = 404) as validation, integrating survival analysis, functional enrichment, immune deconvolution by ssGSEA and MCP-counter, immune checkpoint correlation, and TISCH2-based single-cell localization. Results: TGFB2 was consistently overexpressed in glioma relative to normal brain at both mRNA and protein levels, with expression highest in GBM (median 10.60 vs. 8.45 in LGG; p < 2.2 × 10−16) and increasing across WHO grade. High TGFB2 predicted worse overall survival in both cohorts (TCGA: 648 vs. 2907 days; CGGA: 863 vs. 3107 days; both p < 0.0001), with 3-year AUCs of 0.823 and 0.714, and retained independent prognostic significance in the CGGA multivariate model (HR = 1.343; p = 3.2 × 10−4). Hallmark GSEA identified consistent enrichment of interferon signaling, epithelial–mesenchymal transition, TNFα/NF-κB, and IL-6/JAK/STAT3 pathways. ssGSEA and MCP-counter concordantly demonstrated significantly expanded myeloid, monocytic, and stromal populations across both cohorts. TGFB2 correlated positively with PD-L1, TIM-3, ICOS (ρ = 0.449), IL2RA (ρ = 0.397), CTLA4 (ρ = 0.375), and TIGIT (ρ = 0.170) in TCGA, with all associations replicated in CGGA. Conclusions: TGFB2 is an adverse prognostic biomarker in diffuse glioma coupled to a myeloid-enriched, multi-checkpoint-activated tumor microenvironment, supporting its evaluation as a stratification biomarker in TGF-β/checkpoint combination immunotherapy trials.